We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Salk Institute Receives a $2.3 Million Stem Cell Research Facility Grant

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

The Salk Institute for Biological Studies was awarded a $2.3 million share of the stem cell research facilities grants approved by the governing board of the California Institute for Regenerative Medicine (CIRM) on June 5.

At the Salk, the grant will support the development of shared laboratory space to be used by multiple investigators, and provide an environment for scientific research on human embryonic stem cells (hESCs) under CIRM’s medical and ethical standards. The grant will also provide funds for equipment and operating expenses over three years.

“The availability of this shared research laboratory will allow Salk researchers to initiate research on human embryonic stem cells and to contribute to this very exciting field of biology,” says Program Project Director Inder Verma, Ph.D., a professor in the Laboratory of Genetics, who spearheads the stem cell facility project at the Salk Institute.

“The Salk faculty is also very grateful for the invaluable expertise and help during the planning stages provided by Garry Van Gerpen, senior director of Facility Services, and his staff members, who are the ones who ultimately make it happen,” Verma said.

To date, the Salk Institute has received more than $7.5 million in stem cell research grants from CIRM. Earlier this year, Salk professor Fred H. Gage received $2.9 million for research to develop methods of turning hESCs into neural stem cells; and professors Senyon Choe, Beverly Emerson and Sam Pfaff received seed funding totaling $2.28.